Navigation Links
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
Date:2/3/2009

site via the internet at http://www.neurocrine.com

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program, R & D pipeline and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's GnRH program include risk that the elagolix clinical trials will fail to demonstrate that elagolix is safe and effective; risk that elagolix will not proceed to later stage clinical trials; risks associated with the Company's dependence on corporate collaborators for development, commercial manufacturing and marketing and sales activities. In addition, the Company faces risks and uncertainties with respect to the Company's R & D pipeline including risk that the Company's urocortin 2, CRF1 receptor antagonist, and VMAT2 clinical candidates will not proceed to later stage clinical trials, and risk that the Company's research programs will not identify pre-clinical candidates for further development. The Company also faces risk that the Company may be unable to obtain FDA approval for indiplon commercialization in the near future or at all. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial manufacturing and marketing and sales activities; uncertainties relating to patent p
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
2. Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets
3. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
4. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
5. New Jersey-Based Biotech Start-Up Nexomics Biosciences Gets Off the Ground
6. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
7. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
8. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
9. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
10. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
11. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... September 17, 2014 Operation Smile was founded ... because of a facial deformity.” To spread their message and ... 19, 2014, at the Beverly Wilshire Hotel in Beverly Hills, ... people worldwide whose lives have been forever transformed by the ... be involved with Operation Smile,” said Lynda Erkiletian, Executive Director ...
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 ... launch of two new product extensions, an accompanying ... headquarters, several novel marketing tools for their sales ... Vitamin Angels at their 5th annual national convention, ... room only crowd at the Hyatt Regency Orange ...
(Date:9/16/2014)... September 16, 2014 Pulmonary Hypertension Association Travels ... Education Forum for PH Patients and Families to Help Fight ... – the country’s leading pulmonary hypertension association that works to ... a disease of the lungs that affects the functioning of ... treatment, mean survivability is only 2.8 years. , What:, ...
(Date:9/16/2014)... Kathleen Doheny HealthDay ... A simple urine test can routinely spot human papillomavirus (HPV), ... new analysis found. "Our study shows that testing urine ... taken from the cervix for HPV," said lead researcher Dr. ... and research fellow at Queen Mary University of London, England. ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Cliff Lake Dental ... team. Kristaleen is the newest dental hygienist to join Dr. ... forward to working with her and knows she will bring ... patients. , Kristaleen grew up in River Falls, WI. ... Technical College in 2003 and practiced dental assisting in the ...
Breaking Medicine News(10 mins):Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2
... others interested in the chemical sciences are invited to join ... Webinars, Your Career Matters! featuring speakers that address ... professionals. Scheduled for Thursday, April 8, 2 3 ... Butts, Senior Director of External Science & Technology Programs at ...
... A drug whose clinical benefit in treating multiple sclerosis was ... Food and Drug Administration on January 22 and is now ... is the first therapy for multiple sclerosis that can be ... to treat impaired walking, a debilitating symptom of the disease ...
... health and development consulting group based in Berlin, Germany, ... global health by helping to turn scientific evidence into ... launches this week in San Francisco and Berlin, Germany. ... challenges including HIV, tuberculosis, malaria, and maternal and ...
... ... continues to add improvements and additional resources to help patients considering plastic ... aesthetic goals. Upcoming changes include specific directory "city pages" and a "Request ... their area to follow-up with the request. , ...
... ... security, a new survey of U.S. healthcare organizations suggests that while organizations are updating ... ... As the healthcare industry prepares for a major shift to electronic health records (EHRs) ...
... amphetamines, tranquilizers and antidepressants found in some pills, researchers ... marketed on the Internet as "natural," the popular ... potentially addictive ingredients, researchers say. , The U.S. Food ... associated with the diet pills, but they remain popular ...
Cached Medicine News:Health News:ACS Webinar features tips for finding and building a career in public policy and chemical industry 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 3Health News:New global health initiative will help bridge gap between knowledge, action 2Health News:Cosmetic and Plastic Surgery Web Site Announces Improvements to the Patient Process of Finding Cosmetic Doctors in Their Area 2Health News:Cosmetic and Plastic Surgery Web Site Announces Improvements to the Patient Process of Finding Cosmetic Doctors in Their Area 3Health News:Cosmetic and Plastic Surgery Web Site Announces Improvements to the Patient Process of Finding Cosmetic Doctors in Their Area 4Health News:Cosmetic and Plastic Surgery Web Site Announces Improvements to the Patient Process of Finding Cosmetic Doctors in Their Area 5Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 3Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 4Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 5Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 6Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 7Health News:Online Brazilian Diet Pills Can Be Addictive 2Health News:Online Brazilian Diet Pills Can Be Addictive 3
(Date:9/16/2014)... , Sept. 16, 2014   Evana Automation Specialists ... automated assembly and test systems, recently received a contract ... medical device manufacturer. The Evana solution will help error-proof ... ergonomics, as well as reduce labor. ... to Evana,s robotic assembly cell. The robot will pick ...
(Date:9/16/2014)... , Sept. 16, 2014 On September ... sole exhibition focusing on medical design and manufacturing - ... the Shanghai World Expo Exhibition & Convention Center, bringing ... countries and regions to showcase their latest medical-grade raw ... now only one week remaining for free visitor pre-registration ...
(Date:9/16/2014)... The Lupus Foundation of America and Eli Lilly and ... from UNVEIL: understanding the impact of lupus, a new ... the challenges not only for those living with lupus, ... involved over 1,000 people with lupus and lupus caregivers ... of life including family, work, finances, treatment experiences and ...
Breaking Medicine Technology:Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5
... June 28, 2010 , , ... - Results of First Exposure of Type I Diabetes Patients to Oramed,s Oral,Insulin and of ... , , ... the 2010 Scientific Sessions of the,American Diabetes Association currently being held in Orlando, Florida ...
... Bayer HealthCare Pharmaceuticals today launched FactorTrack™, the first customizable mobile ... and interactive mobile application that helps make it easier to track ... , , ... and locations of bleeds.  It allows people with hemophilia A to ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 2Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 3Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 2Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 3
... The Accutest H. pylori WB ... for the qualitative detection of ... pylori in human whole blood. ... as an aid in the ...
... Rapid 5 minutes immunoassay, based on ... a monoclonal antibody, for the qualitative ... human stool. The Premier Platinum HpSA, ... after extensive evaluation, was accepted as ...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
Medicine Products: